1. Home
  2. Aktienkurse
  3. Aktie Merrimack Pharmaceuticals
Merrimack Pharmaceuticals logo

Merrimack Pharmaceuticals MACK

€ 14.42 0.0%
mail-toFehler melden

Quartalsbericht 2024-Q1
hinzugefügt 15.05.2024

report update icon

Land

 Vereinigte StaatenVereinigte Staaten

IPO-Jahr

 2012

Branche

 Pharmaeinzelhändler

Börse

 NASDAQ GLOBAL

CEO

 Dr. Richard Peters

Mitarbeiter im Unternehmen

 -

Anteile

 14.3 M

Marktkapitalisierung

 $ 216 M

EBITDA (LTM)

 $ -1.65 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Andere Aktien der Branche "Pharmaeinzelhändler"

Name Preis % 24h Marktkapitalisierung Börse Land
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
 		$ 10.41 -5.36 % $ 43.9 M Nasdaq Global Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Advaxis Advaxis
ADXS
 		$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 6.42 - $ 404 M NYSE canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
 		$ 0.56 7.23 % $ 2.72 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		$ 0.5 - $ 7.46 M Nasdaq Global Market israelIsrael
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		$ 179.68 - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		$ 44.15 -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		$ 0.32 - $ 23.9 M Nasdaq Global Select Market usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		$ 18.44 - $ 1.94 B Nasdaq Capital Market canadaCanada
Kaleido Biosciences Kaleido Biosciences
KLDO
 		$ 0.29 -3.69 % $ 12.4 M Nasdaq Global Select Market usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
 		$ 2.19 - $ 105 M Nasdaq Global Market usaUSA
Humanigen Humanigen
HGEN
 		$ 0.04 -81.12 % $ 4.28 M Nasdaq Global Select Market usaUSA